{"transactions":[{"id":3173745,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":149782,"kind":"person","name":"Calias Pericles","position":1,"cik":"0001746282","reported_name":"Calias Pericles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-04-17T20:52:04.000Z","date":"2019-07-16","kind":"tax_withholding","acquired":false,"shares":3246,"price":4.9,"value":15905.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares forfeited to the Issuer in connection with the satisfaction of tax liabilities incurred upon the vesting of restricted stock granted May 24, 2019."}],"balance_after":49216,"source":{"system":"sec-edgar","filing":"0001578563-20-000019","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000157856320000019/primary_doc.xml","form_type":"4"}},{"id":3344844,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":149782,"kind":"person","name":"Calias Pericles","position":1,"cik":"0001746282","reported_name":"Calias Pericles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-12-11T21:15:55.000Z","date":"2019-12-10","kind":"purchase","acquired":true,"shares":2913,"price":2.8475,"value":8294.7675,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan."}],"balance_after":52462,"source":{"system":"sec-edgar","filing":"0001578563-19-000037","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000157856319000037/primary_doc.xml","form_type":"4"}},{"id":3493765,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":149782,"kind":"person","name":"Calias Pericles","position":1,"cik":"0001746282","reported_name":"Calias Pericles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-06-11T23:36:55.000Z","date":"2019-06-10","kind":"purchase","acquired":true,"shares":4549,"price":2.8475,"value":12953.2775,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan."}],"balance_after":49549,"source":{"system":"sec-edgar","filing":"0001578563-19-000020","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000157856319000020/primary_doc.xml","form_type":"4"}},{"id":3508469,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":149782,"kind":"person","name":"Calias Pericles","position":1,"cik":"0001746282","reported_name":"Calias Pericles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-29T21:03:02.000Z","date":"2019-05-24","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth of the shares subject to the stock option will vest on July 16, 2019, and the remaining three-fourths of the shares subject to the stock option will vest in substantially equal monthly installments over the following 36 months, provided the Reporting Person is then still providing continuous service as an employee, director or consultant."}],"balance_after":25000,"derivative":{"exercise_price":4.98,"expiration_date":"2029-05-24","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001578563-19-000018","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000157856319000018/primary_doc.xml","form_type":"4"}},{"id":3508468,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":149782,"kind":"person","name":"Calias Pericles","position":1,"cik":"0001746282","reported_name":"Calias Pericles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-05-29T21:03:02.000Z","date":"2019-05-24","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units vest in four equal installments beginning on July 16, 2019, provided the Reporting Person is then still providing continuous service as an employee, director or consultant."}],"balance_after":45000,"source":{"system":"sec-edgar","filing":"0001578563-19-000018","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000157856319000018/primary_doc.xml","form_type":"4"}},{"id":3567584,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":149782,"kind":"person","name":"Calias Pericles","position":1,"cik":"0001746282","reported_name":"Calias Pericles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-02T23:07:31.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth of the shares subject to the stock option will vest on the first anniversary of the date of grant, and the remaining three-fourths of the shares subject to the stock option will vest in equal monthly installments over the following 36 months."}],"balance_after":175000,"derivative":{"exercise_price":6.22,"expiration_date":"2029-04-01","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001578563-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000157856319000010/primary_doc.xml","form_type":"4"}},{"id":3867145,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":149782,"kind":"person","name":"Calias Pericles","position":1,"cik":"0001746282","reported_name":"Calias Pericles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-16T20:56:07.000Z","date":"2018-07-16","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest 25% on July 16, 2019, and the remaining 75% of the shares subject to the stock option shall vest in 36 equal monthly installments beginning on August 16, 2019, provided the Reporting Person is then an officer of the Issuer on each such vesting date."}],"balance_after":80000,"derivative":{"exercise_price":4.26,"exercise_date":"2019-07-16","expiration_date":"2028-07-15","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001746282-18-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000174628218000003/primary_doc.xml","form_type":"4"}}]}